Gilead Sciences, Inc. (GILD)
Gilead Sciences' HIV prevention drug, lenacapavir, receives EU approval and is hailed for its potential to combat stigma. The drug has shown a 99.9% efficacy rate in preventing HIV in clinical trials.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a biopharmaceutical company focused on developing and commercializing innovative medicines.
Gilead Sciences, Inc. uses the ticker $GILD for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Gilead Sciences, Inc. (GILD) sentiment is up 40.85% from the previous week.
- Gilead Sciences, Inc. (GILD) creators is up 91.06% from the previous month.
- Gilead Sciences, Inc. (GILD) mentions is up 66.67% from the previous month.
- Gilead Sciences, Inc. (GILD) posts created is up 96.04% from the previous month.
- Gilead Sciences, Inc. Price hit a 52-Week high of $156.70 for the hour
- Gilead Sciences, Inc. Price hit an all time of $156.70 for the hour
Price: $155
Price 24-Hour Time-Series Raw Data
The stock price surged to a 52-week high driven by positive developments in HIV prevention and increased social media buzz, but experienced a dip in after-hours trading due to earnings guidance that missed analyst expectations.
24-Hour: -0.31% 7-Day: 1.87% 30-Day: 24.09%
1-Year High: $155.80 on 2026-02-11
1-Year Low: $96.90 on 2025-05-10
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Gilead Sciences, Inc. (GILD) is currently AltRank #637 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +340
[--] Month: [---] +343
[--] Months: [---] +257
[--] Year: [---] +528
1-Year High: [-----] on 2025-07-12
1-Year Low: [--] on 2025-03-03
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-05-20
1-Year Low: [--] on 2026-01-28
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] -23%
[--] Month: [---------] +183%
[--] Months: [----------] -19%
[--] Year: [----------] -7.50%
1-Year High: [---------] on 2025-07-22
1-Year Low: [-----] on 2025-12-27
Engagements by network (24h): News: [--] Instagram: [---] Reddit: [--] TikTok: [-----] YouTube: [---] X: [------]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] +21%
[--] Month: [-----] +67%
[--] Months: [------] -5.50%
[--] Year: [------] -15%
1-Year High: [-----] on 2025-06-27
1-Year Low: [---] on 2025-12-07
Mentions by network (24h): News: [--] Instagram: [--] Reddit: [--] TikTok: [--] YouTube: [--] X: [---]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Gilead Sciences, Inc. (GILD) in the last [--] hours which is down 18% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +19%
[--] Month: [-----] +91%
[--] Months: [-----] +22%
[--] Year: [------] +118%
1-Year High: [-----] on 2025-06-27
1-Year Low: [---] on 2025-12-14
The most influential creators that mention Gilead Sciences, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @IdenixH | [--] | [---] | [--] | [-----] |
| @eWhispers | [--] | [-------] | [--] | [---] |
| @AmeliaVilla | [--] | [--] | [--] | [---] |
| @BrandonVanZee | [--] | [------] | [--] | [---] |
| @onlinetawsiat2 | [--] | [-----] | [--] | [---] |
| @SamFazeli8 | [--] | [-----] | [--] | [---] |
| @monroealise | [--] | [------] | [--] | [---] |
| @GileadSciences | [--] | [------] | [--] | [---] |
| @gileadsciencesinc | [--] | [-----] | [--] | [---] |
| @fwpharma | [--] | [------] | [--] | [--] |
Sentiment: 87%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 87%
Daily Average: 82%
[--] Week: 100% +29%
[--] Month: 85% +13%
[--] Months: 85% -2%
[--] Year: 85% +5%
1-Year High: 97% on 2025-10-28
1-Year Low: 62% on 2025-03-10
Most Supportive Themes:
- HIV Prevention Breakthroughs: (30%) Gilead's lenacapavir drug for HIV prevention has received approval in South Africa, offering new hope.
- US Manufacturing Investment: (20%) Gilead Sciences is investing $11 billion in domestic manufacturing and research within the United States.
- Positive Sentiment and Engagement: (25%) Social sentiment is up and creator activity has increased significantly, indicating growing community interest.
Most Critical Themes:
- Potential Revenue Impact from Drug Price Cuts: (40%) A proposed executive order to cut drug prices could significantly impact Gilead Sciences' revenue.
Social Dominance: 0.042%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.042%
Daily Average: 0.08%
[--] Week: 0.04% -0.00528%
[--] Month: 0.065% +0.01%
[--] Months: 0.065% -0.04%
[--] Year: 0.065% -0.075%
1-Year High: 0.216% on 2025-06-27
1-Year Low: 0.03% on 2025-12-07
Market Dominance: 0.219%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.219%
Daily Average: 0%
1-Year High: 0.279% on 2025-03-12
1-Year Low: 0.166% on 2025-10-02
Market Cap: $191,685,001,754
Market Cap 24-Hour Time-Series Raw Data
Current Value: $191,685,001,754
Daily Average: $144,764,927,979
[--] Week: $191,883,510,493 +2.40%
[--] Month: $191,883,510,493 +24%
[--] Months: $191,883,510,493 +33%
[--] Year: $191,883,510,493 +48%
1-Year High: $193,297,885,263 on 2026-02-11
1-Year Low: $120,549,171,116 on 2025-05-09
Top Gilead Sciences, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"A twice-yearly injection of this new drug can prevent high-risk populations from catching #HIV. Now the EU has given it a green light. Heres how #lenacapavir works and what its manufacturer Gilead Sciences is doing to broaden access to poorer countries. We also hear from Winnie Byanyima Executive Director of @UN Aids on how the long-acting medication can help alleviate stigma and discrimination. The World Economic Forums Health For All initiative aims to foster a world where everyone can access quality healthcare regardless of background or income. Tap the link in our bio to find out more"
TikTok Link @worldeconomicforum 2025-09-05T16:03Z 1.7M followers, 494K engagements
"The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug called Yeztugo from company Gilead Sciences was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative"
TikTok Link @cbsmornings 2025-06-19T11:53Z 3.8M followers, 1M engagements
"non traditional nursing job with biotech Companies to search #tirednurse #nontraditionalnursing #nontraditionalnurse #wholelifenurse #nursesoftiktok Novo Nordisk Thermo Fisher Scientific Amgen CSL Gilead Sciences Regeneron Pharmaceuticals Vertex Pharmaceuticals Moderna Chugai Pharmaceutical Illumina Lonza WuXi AppTec Samsung Biologics Agilent Technologies Jiangsu Hengrui Medicine BioNTech WuXi Biologics Biogen Sun Pharmaceutical Industries Seagen Genmab UCB Celltrion Incyte Charles River Laboratories Non Traditional Biotech Jobs for Nurses Novo Nordisk Thermo Fisher Scientific Amgen CSL"
TikTok Link @wholelifenurse 2022-08-20T13:31Z 77.3K followers, 877.7K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing